Patient no. | Age (years) | Gender | Diagnosis | SARA | ICARS | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total (40) | GSS (18) | SP (6) | UL (12) | LL (4) | Total (100) | GSS (34) | UL (44) | LL (8) | SP (8) | OC (6) | ||||
Cer 01 | 43 | M | SAOA | 8 | 4 | 2 | 1 | 1 | 18 | 11 | 3 | 2 | 2 | 0 |
Cer 02 | 65 | F | SAOA | 9 | 3 | 2 | 2 | 2 | 18 | 7 | 4 | 4 | 2 | 1 |
Cer 03 | 73 | F | SCA 6 | 11 | 3 | 2 | 4 | 2 | 29 | 7 | 5 | 10 | 4 | 3 |
Cer 04 | 60 | M | SAOA | 9 | 2 | 2 | 2 | 3 | 20 | 6 | 3 | 7 | 2 | 2 |
Cer 05 | 33 | F | SAOA | 13.5 | 6 | 1 | 3.5 | 3 | 34 | 17 | 7 | 4 | 2 | 4 |
Cer 06 | 48 | M | SAOA | 13.5 | 5 | 2 | 4 | 2.5 | 37 | 15 | 9 | 4 | 4 | 5 |
Cer 07 | 45 | M | SCA 14 | 5.5 | 2 | 1 | 1.5 | 1 | 24 | 8 | 6 | 4 | 3 | 3 |
Cer 08 | 47 | F | ADCA III | 8 | 2 | 2 | 2.5 | 1.5 | 14 | 5 | 3 | 2 | 3 | 1 |
Cer 09 | 52 | M | SCA 6 | 2.5 | 2 | 0 | 0.5 | 0 | 9 | 3 | 0 | 0 | 0 | 6 |
Cer 10 | 63 | F | SCA 6 | 19.5 | 10 | 2 | 4.5 | 3 | 50 | 24 | 10 | 10 | 4 | 2 |
Cer 11 | 71 | M | SAOA | 5 | 1 | 0 | 2 | 2 | 17 | 5 | 3 | 4 | 0 | 5 |
Cer 12 | 27 | M | SAOA | 12 | 3 | 2 | 5 | 2 | 28 | 9 | 12 | 4 | 2 | 1 |
Mean | 52.3 | 9.7 | 3.6 | 1.5 | 3.0 | 1.9 | 24.9 | 9.8 | 5.4 | 4.6 | 2.3 | 2.8 |
SARA, Scale for the Assessment and Rating of Ataxia (Schmitz-Hübsch et al., 2006); ICARS, International Cooperative Ataxia Rating Scale (Trouillas et al., 1997); GSS, subscore for gait, stance, and sitting; SP, subscore for speech; UL, subscore for upper limb kinetic function; LL, subscore for lower limb kinetic function; OC, subscore for oculomotor function; maximal scores for ICARS, SARA, and respective subscores are provided in parentheses; a higher score refers to worse ataxia; M, male; F, female; SAOA, sporadic adult onset ataxia of unknown etiology; SCA 6/14, spinocerebellar ataxia type 6/14 (pure cerebellar); ADCA III, autosomal dominant cerebellar ataxia type III (pure cerebellar).